Also, as we only collected clinicopathological factors through chart reviews, the biological backgrounds of patients (e.g. somatic gene mutation, PD-L1 status, cell-free DNA, etc.)could not be identified, which could play a key role in those with high tumor burdens. This evidence concerns the gene CD274 and neoplasm.